carbamates has been researched along with gallic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dugdale, M; Johnson, RW; Lasslo, A; Naylor, JL; Quintana, RP | 1 |
| Greeson, J; Lecanu, L; McCourty, A; Papadopoulos, V; Rammouz, G; Tillement, L; Yao, W | 1 |
2 other study(ies) available for carbamates and gallic acid
| Article | Year |
|---|---|
Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profile.
Topics: Adenosine Diphosphate; Arachidonic Acid; Arachidonic Acids; Aspirin; Calcimycin; Calcium; Calcium Channel Blockers; Carbamates; Chlorpromazine; Gallic Acid; Humans; In Vitro Techniques; Piperidines; Platelet Aggregation; Propranolol; Thrombin | 1984 |
Dimethyl-carbamic acid 2,3-Bis-Dimethylcarbamoyloxy-6-(4-Ethyl-Piperazine-1-Carbonyl)-phenyl ester: a novel multi-target therapeutic approach to neuroprotection.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Brain; Carbamates; Cholinesterase Inhibitors; Gallic Acid; GPI-Linked Proteins; HEK293 Cells; Humans; Male; Mitochondria; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Piperazines; Prodrugs; Rats; Rats, Long-Evans; Receptors, sigma; Sigma-1 Receptor | 2010 |